Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 2
1951 1
1954 1
1956 1
1957 1
1958 1
1959 1
1960 2
1961 1
1962 2
1964 1
1965 1
1966 1
1967 2
1968 1
1969 1
1970 7
1971 8
1972 13
1973 7
1974 9
1975 8
1976 15
1977 10
1978 4
1979 4
1980 4
1981 8
1982 2
1983 4
1984 6
1985 5
1986 7
1987 10
1988 7
1989 11
1990 3
1991 8
1992 7
1993 7
1994 8
1995 5
1996 17
1997 18
1998 9
1999 4
2000 8
2001 6
2002 13
2003 6
2004 8
2005 12
2006 18
2007 8
2008 13
2009 15
2010 5
2011 18
2012 18
2013 16
2014 14
2015 18
2016 27
2017 11
2018 17
2019 18
2020 19
2021 12
2022 9
2023 6
2024 4
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

550 results

Results by year

Filters applied: . Clear all
Page 1
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Ray-Coquard I, Pautier P, Pignata S, Pérol D, González-Martín A, Berger R, Fujiwara K, Vergote I, Colombo N, Mäenpää J, Selle F, Sehouli J, Lorusso D, Guerra Alía EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marmé F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges A, You B, Pujade-Lauraine E, Harter P; PAOLA-1 Investigators. Ray-Coquard I, et al. N Engl J Med. 2019 Dec 19;381(25):2416-2428. doi: 10.1056/NEJMoa1911361. N Engl J Med. 2019. PMID: 31851799 Clinical Trial.
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Pfisterer J, Shannon CM, Baumann K, Rau J, Harter P, Joly F, Sehouli J, Canzler U, Schmalfeldt B, Dean AP, Hein A, Zeimet AG, Hanker LC, Petit T, Marmé F, El-Balat A, Glasspool R, de Gregorio N, Mahner S, Meniawy TM, Park-Simon TW, Mouret-Reynier MA, Costan C, Meier W, Reinthaller A, Goh JC, L'Haridon T, Baron Hay S, Kommoss S, du Bois A, Kurtz JE; AGO-OVAR 2.21/ENGOT-ov 18 Investigators. Pfisterer J, et al. Among authors: meier w. Lancet Oncol. 2020 May;21(5):699-709. doi: 10.1016/S1470-2045(20)30142-X. Epub 2020 Apr 16. Lancet Oncol. 2020. PMID: 32305099 Free article. Clinical Trial.
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.
Harter P, Sehouli J, Vergote I, Ferron G, Reuss A, Meier W, Greggi S, Mosgaard BJ, Selle F, Guyon F, Pomel C, Lécuru F, Zang R, Avall-Lundqvist E, Kim JW, Ponce J, Raspagliesi F, Kristensen G, Classe JM, Hillemanns P, Jensen P, Hasenburg A, Ghaem-Maghami S, Mirza MR, Lund B, Reinthaller A, Santaballa A, Olaitan A, Hilpert F, du Bois A; DESKTOP III Investigators. Harter P, et al. Among authors: meier w. N Engl J Med. 2021 Dec 2;385(23):2123-2131. doi: 10.1056/NEJMoa2103294. N Engl J Med. 2021. PMID: 34874631 Clinical Trial.
Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer.
Ledermann J, Harter P, Gourley C, Friedlander M, Vergote I, Rustin G, Scott C, Meier W, Shapira-Frommer R, Safra T, Matei D, Macpherson E, Watkins C, Carmichael J, Matulonis U. Ledermann J, et al. Among authors: meier w. N Engl J Med. 2012 Apr 12;366(15):1382-92. doi: 10.1056/NEJMoa1105535. Epub 2012 Mar 27. N Engl J Med. 2012. PMID: 22452356 Free article. Clinical Trial.
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms.
Harter P, Sehouli J, Lorusso D, Reuss A, Vergote I, Marth C, Kim JW, Raspagliesi F, Lampe B, Aletti G, Meier W, Cibula D, Mustea A, Mahner S, Runnebaum IB, Schmalfeldt B, Burges A, Kimmig R, Scambia G, Greggi S, Hilpert F, Hasenburg A, Hillemanns P, Giorda G, von Leffern I, Schade-Brittinger C, Wagner U, du Bois A. Harter P, et al. Among authors: meier w. N Engl J Med. 2019 Feb 28;380(9):822-832. doi: 10.1056/NEJMoa1808424. N Engl J Med. 2019. PMID: 30811909 Free article. Clinical Trial.
Interfacing Functional Systems.
Cotelle Y, Chuard N, Lascano S, Lebrun V, Wehlauch R, Bohni N, Lörcher S, Postupalenko V, Reddy ST, Meier W, Palivan CG, Gademann K, Ward TR, Matile S. Cotelle Y, et al. Among authors: meier w. Chimia (Aarau). 2016;70(6):418-23. doi: 10.2533/chimia.2016.418. Chimia (Aarau). 2016. PMID: 27363370 Free article. Review.
Liposome-based nanocapsules.
Ruysschaert T, Germain M, Gomes JF, Fournier D, Sukhorukov GB, Meier W, Winterhalter M. Ruysschaert T, et al. Among authors: meier w. IEEE Trans Nanobioscience. 2004 Mar;3(1):49-55. doi: 10.1109/tnb.2004.824273. IEEE Trans Nanobioscience. 2004. PMID: 15382644
Biomimetic Polymer Architectures.
Gunkel-Grabole G, Meier W. Gunkel-Grabole G, et al. Among authors: meier w. Chimia (Aarau). 2018 Aug 22;72(7):548. doi: 10.2533/chimia.2018.548. Chimia (Aarau). 2018. PMID: 30158019 Free article. No abstract available.
Synthetic Biology: Bottom-Up Assembly of Molecular Systems.
Hirschi S, Ward TR, Meier WP, Müller DJ, Fotiadis D. Hirschi S, et al. Among authors: meier wp. Chem Rev. 2022 Nov 9;122(21):16294-16328. doi: 10.1021/acs.chemrev.2c00339. Epub 2022 Sep 30. Chem Rev. 2022. PMID: 36179355 Review.
550 results